Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

Mozambique's Health Minister Reviews Country's Health Status With Parliament
A nationwide vaccination effort in Mozambique helped to slash the number of reported cases of measles in Mozambique in 2008, Health Minister Ivo Garrido said Wednesday when addressing the country"s parliament, Agencia de Informacao de Mocambique/allAfrica.com reports.
generic viagra online
Hospital Pharmacists Launch Pioneering Healthy Lifestyle Scheme, UK
Inpatients at Southampton"s teaching hospitals are to be offered advice on lifestyle and weight management as part of a radical new project. Southampton University Hospitals NHS Trust"s pharmacy team has invented an innovative plan to tackle obesity during routine risk assessments for venous thromboembolism (VTE), better known as blood clots.
News of the day
Advance Toward New Drugs That Turn Genes On And Off
Scientists in Michigan and California are reporting an advance toward development of a new generation of drugs that treat disease by orchestrating how genes in the body produce proteins involved in arthritis, cancer and a range of other disorders. Acting like an "on-off switch," the medications might ratchet up the production of proteins in genes working at abnormally low levels or shut off genes producing an abnormal protein linked to disease. Their report is in the current issue of ACS Chemical Biology, a monthly journal.
Medical Devices

Radiant Research, Inc. Prepares For Upcoming H1N1 Vaccine Trials

Radiant Research, Inc. announced that it is actively recruiting subjects and establishing operational plans for upcoming H1N1 vaccine trials. The World Health Organization declared the H1N1 influenza outbreak a pandemic, and the CDC has shipped virus samples to several manufacturers with the hope of having vaccine available to the general public by the fall. Manufacturers will need to complete clinical trials prior to release of vaccine to the public. "Our research sites are ideal for this type of clinical trial," said Julie McHugh, Vice President of Late Phase Clinical Research, Radiant Research, Inc. "We have conducted over 200 vaccine trials and enrolled thousands of subjects into these trials in the past five years. We know how to enroll these trials quickly and efficiently, and we enforce the standards that ensure quality data collection." "We have over a million subjects in our database and they are both familiar with the research process and very interested in this type of trial," said Michael Kritschgau, Vice President of Radiant Recruitment. "We are currently making contact with these potential subjects so we can be ready to enroll once the manufacturers are ready to move to the clinical trials stage. We anticipate that companies producing the vaccine will soon be reaching out to various research. Radiant Research, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009